Literature DB >> 32537563

A focused review of cardiovascular guideline related recommendations for the primary care physician in the USA.

Omar Sheikh1, Mouhamed Nashawi1, Ayman Battisha2, Robert Chilton1.   

Abstract

Primary care physicians in the USA serve the critical role of first contact for undiagnosed or mismanaged pathologies as well as providers of continuous care in multiple communities. Their scope of practice is broad from medication reconciliation to coordinating specialty care and even performing office procedures. Primary care physicians in the USA commonly encounter patients with diabetes and associated comorbidities related to prolonged insulin resistance. Mainly these include heart failure exacerbation or major adverse cardiovascular events. The demanding roles primary care physicians serve may render these providers encumbered to navigate through long, verbose and dynamic guidelines related to managing diabetes and cardiac diabetology sequelae. Our aim is to compose current, prominent evidence-based points from American medical societies such as the American College of Cardiology/American Heart Association and the American Diabetes Association central to lifestyle modifications, antiplatelet therapy, anti-hyperglycemic and SGLT2-inhibitor utilization, hypertension, dyslipidemia, and heart failure screening in a way that is both succinct and valuable to primary care physicians.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Keywords:  SGLT2 inhibitors; cardiovascular; diabetes; guidelines; hypertension; preventive; primary care physician

Year:  2020        PMID: 32537563      PMCID: PMC7228774          DOI: 10.1097/XCE.0000000000000192

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


  24 in total

Review 1.  American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from?

Authors:  Raymond J Gibbons; Sidney Smith; Elliott Antman
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

2.  CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

Authors:  Alan J Garber; Martin J Abrahamson; Joshua I Barzilay; Lawrence Blonde; Zachary T Bloomgarden; Michael A Bush; Samuel Dagogo-Jack; Ralph A DeFronzo; Daniel Einhorn; Vivian A Fonseca; Jeffrey R Garber; W Timothy Garvey; George Grunberger; Yehuda Handelsman; Irl B Hirsch; Paul S Jellinger; Janet B McGill; Jeffrey I Mechanick; Paul D Rosenblit; Guillermo E Umpierrez
Journal:  Endocr Pract       Date:  2019-01       Impact factor: 3.443

3.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  J Am Coll Cardiol       Date:  2017-04-28       Impact factor: 24.094

4.  New York Heart Association Classification.

Authors:  J D Fisher
Journal:  Arch Intern Med       Date:  1972-05

5.  Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels.

Authors:  Lori B Daniels; Paul Clopton; Kevin Jiang; Barry Greenberg; Alan S Maisel
Journal:  J Card Fail       Date:  2009-11-14       Impact factor: 5.712

Review 6.  The pathophysiology of heart failure.

Authors:  Clinton D Kemp; John V Conte
Journal:  Cardiovasc Pathol       Date:  2012-01-05       Impact factor: 2.185

7.  Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study.

Authors:  Johan Lassus; Etienne Gayat; Christian Mueller; W Frank Peacock; Jindrich Spinar; Veli-Pekka Harjola; Roland van Kimmenade; Atul Pathak; Thomas Mueller; Salvatore Disomma; Marco Metra; Domingo Pascual-Figal; Said Laribi; Damien Logeart; Semir Nouira; Naoki Sato; Michael Potocki; Jiri Parenica; Corinne Collet; Alain Cohen-Solal; James L Januzzi; Alexandre Mebazaa
Journal:  Int J Cardiol       Date:  2013-03-26       Impact factor: 4.164

Review 8.  Barriers to effective management of type 2 diabetes in primary care: qualitative systematic review.

Authors:  Bruno Rushforth; Carolyn McCrorie; Liz Glidewell; Eleanor Midgley; Robbie Foy
Journal:  Br J Gen Pract       Date:  2016-02       Impact factor: 5.386

Review 9.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

10.  Standards of Medical Care in Diabetes-2019 Abridged for Primary Care Providers.

Authors: 
Journal:  Clin Diabetes       Date:  2019-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.